News

D-Wave Quantum (NYSE:QBTS) dips over 7% despite rolling out its Advantage2 system and warning the U.S. trails rivals in quantum annealing. D-Wave's latest Advantage2 machine is live in 40+ countries ...
Cathay Innovation said Tuesday it has closed its Fund III at $1 billion and will continue to back AI startups in digital ...
Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro, Inc.
In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG ...
AI researchers, clinicians and entrepreneurs explored the potential of AI for healthcare at a showcase Imperial Global USA event in San Francisco.An ...
SCOTTSDALE, Ariz., May 27, 2025 /PRNewswire/ -- Life365, a leading data engagement and virtual care company, today announced the appointment of healthcare executive and investor Jay Roberts as chief ...
Recursion Pharmaceuticals and Schrodinger leverage their respective AI drug discovery platforms to potentially develop distinguished therapeutic candidates.
Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a leader in Modernisation Engineering, today announced a partnership with Qualtrics the leader and creator of the Experience Management (XM) category, ...
Contrary to a press release issued by RENB, the Delaware Court of Chancery recently rejected RENB's request for an expedited, ...
Learn about Capex trends, data center growth, and how to invest in the infrastructure powering generative AI. Discover how hyperscaler capex is driving the future of cloud computing and AI.
GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles ...